参考文献/References:
[1]Cole JB,Florez JC. Genetics of diabetes mellitus and diabetes complications[J]. Nat Rev Nephrol,2020,16(7):377-390.
[2]Henning RJ. Type-2 diabetes mellitus and cardiovascular disease[J]. Future Cardiol,2018,14(6):491-509.
[3]Hong L,Zha Y,Wang C,et al. Folic acid alleviates high glucose and fat-induced pyroptosis via inhibition of the hippo signal pathway on H9C2 cells[J]. Front Mol Biosci,2021,8:698698.
[4]Ingelfinger JR,Jarcho JA. Increase in the incidence of diabetes and its implications[J]. N Engl J Med,2017,376(15):1473-1474.
[5]Schmidt AM. Highlighting diabetes mellitus:the epidemic continues[J]. Arterioscler Thromb Vasc Biol,2018,38(1):e1-e8.
[6]Tate M,Perera N,Prakoso D,et al. Bone morphogenetic protein 7 gene delivery improves cardiac structure and function in a murine model of diabetic cardiomyopathy[J]. Front Pharmacol,2021,12:719290.
[7]Tsai MF,Phillips CB,Ranaghan M,et al.?Dual functions of a small regulatory subunit in the mitochondrial calcium uniporter complex[J].?Elife,2016,5:e15545.
[8]Demaurex N,Rosselin M. Redox control of mitochondrial calcium uptake[J]. Mol Cell,2017,65(6):961-962.
[9]Shah SI,Ullah G. The function of mitochondrial calcium uniporter at the whole-cell and single mitochondrion levels in WT,MICU1 KO,and MICU2 KO cells[J]. Cells,2020,9(6):1520.
[10]Nemani N,Shanmughapriya S,Madesh M. Molecular regulation of MCU:implications in physiology and disease[J]. Cell Calcium,2018,74:86-93.
[11]Wang C,Baradaran R,Long SB. Structure and reconstitution of an MCU-EMRE mitochondrial Ca2+ uniporter complex[J]. J Mol Biol,2020,432(20):5632-5648.
[12]Cloete L. Diabete mellitus:an overview of the types,symptoms,complications and management[J]. Nurs Stand,2022,37(1):61-66.
[13]Endlicher R,Drahota Z,Ku?era O,et al. Age-dependent changes in the function of mitochondrial membrane permeability transition pore in rat liver mitochondria[J]. Physiol Res,2021,70(6):905-911.
[14]荆哲,刘峰舟,王炜中,等. EMRE对高糖高脂诱导心肌细胞凋亡的影响[J]. 心脏杂志,2016,28(3):285-288.
[15]Singh RM,Waqar T,Howarth FC,et al. Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart[J]. Heart Fail Rev,2018,23(1):37-54.
[16]Jia G,Whaley-Connell A,Sowers JR. Diabetic cardiomyopathy:a hyperglycaemia- and insulin-resistance-induced heart disease[J]. Diabetologia,2018,61(1):21-28.
[17]Kho C,Lee A,Jeong D,et al. Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure[J]. Nat Commun,2015,6:7229.
[18]Kanter JE,Bornfeldt KE. Impact of diabetes mellitus[J]. Arterioscler Thromb Vasc Biol,2016,36(6):1049-1053.
[19]Seferovi? PM,Petrie MC,Filippatos GS,et al. Type 2 diabetes mellitus and heart failure:a position statement from the Heart Failure Association of the European Society of Cardiology[J]. Eur J Heart Fail,2018,20(5):853-872.
[20]Bugger H,Abel ED. Molecular mechanisms of diabetic cardiomyopathy[J]. Diabetologia,2014,57(4):660-671.
[21]Tanwar J,Singh JB,Motiani RK. Molecular machinery regulating mitochondrial calcium levels:The nuts and bolts of mitochondrial calcium dynamics[J]. Mitochondrion,2021,57:9-22.
[22]Ryan KC,Ashkavand Z,Norman KR. The role of mitochondrial calcium homeostasis in Alzheimer’s and related diseases[J]. Int J Mol Sci,2020,21(23):9153.
[23]Ferreira JP,Verdonschot J,Collier T,et al. Proteomic bioprofiles and mechanistic pathways of progression to heart failure[J]. Circ Heart Fail,2019,12(5):e005897.
[24]Annesley SJ,Fisher PR. Mitochondria in health and disease[J]. Cells,2019,8(7):680.
[25]Arnoult D,Gaume B,Karbowski M,et al. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization[J]. EMBO J,2003,22(17):4385-4399.
[26]Kalkavan H,Green DR. MOMP,cell suicide as a BCL-2 family business[J]. Cell Death Differ,2018,25(1):46-55.
[27]Cheung CHA,Chang YC,Lin TY,et al. Anti-apoptotic proteins in the autophagic world:an update on functions of XIAP,Survivin,and BRUCE[J]. J Biomed Sci,2020,27(1):31.
[28]Chakrabarti S,Munshi S,Banerjee K,et al. Mitochondrial dysfunction during brain aging:role of oxidative stress and modulation by antioxidant supplementation[J]. Aging Dis,2011,2(3):242-256.
[29]Chang JY,Yi HS,Kim HW,et al. Dysregulation of mitophagy in carcinogenesis and tumor progression[J]. Biochim Biophys Acta Bioenerg,2017,1858(8):633-640.
[30]Stefanatos R,Sanz A. The role of mitochondrial ROS in the aging brain[J]. FEBS Lett,2018,592(5):743-758.
[31]Slimen IB,Najar T,Ghram A,et al. Reactive oxygen species,heat stress and oxidative-induced mitochondrial damage. A review[J]. Int J Hyperthermia,2014,30(7):513-523.
相似文献/References:
[1]付辉,黄鹤.线粒体功能障碍在心血管疾病中的作用[J].心血管病学进展,2020,(3):306.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.022]
FU Hui,HUANG He.Role of Mitochondrial Dysfunction in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(10):306.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.022]
[2]韩敏 朱兵 余嘉清 马依彤.程序性细胞死亡与心肌缺血再灌注损伤[J].心血管病学进展,2020,(10):1069.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.017]
HAN MinZHU BingYU JiaqingMA Yitong.  Programmed Cell Death and Myocardial Ischemic Reperfusion Injury[J].Advances in Cardiovascular Diseases,2020,(10):1069.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.017]
[3]张彩霞 曾彬 廖小婷.心肌梗死模型中三碘甲状腺原氨酸对心肌的保护作用研究[J].心血管病学进展,2020,(11):1209.[doi:10.16806/j.cnki.issn.1004-3934.20.11.000]
ZHANG Caixia,ZENG Bin,LIAO Xiaoting.Protective Effect of Triiodothyronine on Myocardium in Myocardial Infarction Model[J].Advances in Cardiovascular Diseases,2020,(10):1209.[doi:10.16806/j.cnki.issn.1004-3934.20.11.000]
[4]杨帆 吴建军.五味子乙素通过半胱天冬酶凋亡途径对抗高糖诱导的心肌细胞氧化应激损伤[J].心血管病学进展,2022,(2):188.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.022]
YANG Fan,WU Jianjun.Sch.B Protects High Glucose-Induced Cardiomyocytes from Oxidative Stress Injury via Caspase Pathway[J].Advances in Cardiovascular Diseases,2022,(10):188.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.022]
[5]郭双 吕勃.细胞凋亡和程序性坏死在心肌缺血再灌注损伤中的作用研究[J].心血管病学进展,2022,(12):1148.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.020]
GUO Shuang L YU Bo.The Role of Apoptosis and Necroptosis in Myocardial Ischemia-Reperfusion Injury[J].Advances in Cardiovascular Diseases,2022,(10):1148.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.020]
[6]高璐阳 金旗 张毅 李欣 黄志华 章思铖 段安琪 赵智慧 赵青 罗勤 柳志红.PI3K/Akt/FoxO1信号通路对人源肺动脉平滑肌细胞及肺动脉高压大鼠细胞凋亡的影响[J].心血管病学进展,2024,(1):79.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.020]
GAO Luyang,JIN Qi,ZHANG Yi,et al.Effect of PI3K/Akt/FoxO1 Signaling Pathway on Apoptosis in Human Pulmonary Artery Smooth Muscle Cell and Pulmonary Hypertension Rat[J].Advances in Cardiovascular Diseases,2024,(10):79.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.020]
[7]李铭,高继先,吴冰,等.卡格列净减轻心肌梗死后细胞凋亡及炎症反应改善预后[J].心血管病学进展,2024,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.018]
LI Ming,GAO Jixian,WU Bing,et al.Canagliflozin alleviates apoptosis and inflammation after myocardial infarction, and improves prognosis[J].Advances in Cardiovascular Diseases,2024,(10):368.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.018]
[8]文江艳 滕藤 唐其柱.黄杞苷减轻H9c2细胞的缺氧再复氧损伤[J].心血管病学进展,2024,(6):566.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.020]
WEN Jiangyan,TENG Teng,TANG Qizhu.Engeletin Alleviates Hypoxia Reoxygenation Injury in H9c2 Cells[J].Advances in Cardiovascular Diseases,2024,(10):566.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.020]
[9]郭红豆 蒋凌 罗顺祥 陈甘潇 林佳仪 林奕帆 徐尚华.小白菊内酯对多柔比星诱导的H9c2心肌细胞损伤保护作用的相关机制研究[J].心血管病学进展,2024,(7):666.[doi:10.16806/j.cnki.issn.1004-3934.2024.07.019]
GUO HongdouJIANG Lin,LUO Shunxiang,CHEN Ganxiao,et al.Study on the Protective Effects and Mechanisms of Parthenolide Against Doxorubicin-Induced H9c2 Cardiomyocyte Injury[J].Advances in Cardiovascular Diseases,2024,(10):666.[doi:10.16806/j.cnki.issn.1004-3934.2024.07.019]